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Abstract
Background: Polymeric alkylpyridinium salts (poly-APS), are chemical defences produced by marine sponges including
Reniera sarai. Poly-APS have previously been shown to effectively deliver macromolecules into cells. The efficiency of this
closely follows the ability of poly-APS to form transient pores in membranes, providing strong support for a pore-based
delivery mechanism. Recently, water soluble compounds have been synthesised that are structurally related to the
natural polymers but bear a different number of pyridinium units. These compounds may share a number of bio-activities
with poly-APS. Using electrophysiology, calcium imaging and 1,6-diphenyl-1,3,5-hexatriene imaging, the pore forming
properties of poly-APS and four related synthetic oligomers have been tested on primary cultured rat hippocampal
neurones.
Results: Acute application of poly-APS (0.5 μg/ml), reduced membrane potential, input resistance and suppressed action
potential firing. Poly-APS evoked inward cation currents with linear current-voltage relationships similar to actions of
pore formers on other cell types. Poly-APS (0.005–5 μg/ml) also produced Ca2+ transients in ~41% of neurones. The
dose-dependence of poly-APS actions were complex, such that at 0.05 μg/ml and 5 μg/ml poly-APS produced varying
magnitudes of membrane permeability depending on the order of application. Data from surface plasmon resonance
analysis suggested accumulation of poly-APS in membranes and subsequent enhanced poly-APS binding. Even at 10–100
fold higher concentrations, none of the synthetic compounds produced changes in electrophysiological characteristics of
the same magnitude as poly-APS. Of the synthetic oligomers tested compounds 1 (monomeric) and tetrameric 4 (5–50
μg/ml) induced small transient currents and 3 (trimeric) and 4 (tetrameric) produced significant Ca2+ transients in
hippocampal neurones.
Conclusion: Poly-APS induced pore formation in hippocampal neurones and such pores were transient, with neurones
recovering from exposure to these polymers. Synthetic structurally related oligomers were not potent pore formers
when compared to poly-APS and affected a smaller percentage of the hippocampal neurone population. Poly-APS may
have potential as agents for macromolecular delivery into CNS neurones however; the smaller synthetic oligomers tested
in this study show little potential for such use. This comparative analysis indicated that the level of polymerisation giving
rise to the supermolecular structure in the natural compounds, is likely to be responsible for the activity here reported.
Published: 2 February 2007
BMC Pharmacology 2007, 7:1 doi:10.1186/1471-2210-7-1
Received: 27 April 2006
Accepted: 2 February 2007
This article is available from: http://www.biomedcentral.com/1471-2210/7/1
© 2007 Koss et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 17
(page number not for citation purposes)
BMC Pharmacology 2007, 7:1 http://www.biomedcentral.com/1471-2210/7/1Background
Poly-APS bioactivities and transfection
Polymeric 1,3-alkylpyridinium salts (poly-APS), have
been isolated from water soluble extracts of the marine
sponge Reniera sarai. The preparation contains a mixture
of oligomeric and polymeric alkylpyridinium compounds
but two primary polymeric compounds, one of 5.52 kDa
and one of 18.9 kDa are predominant (containing 29 or
99 repeats; Figure 1). Poly-APS are amphipathic mole-
cules expressing both a hydrophilic cationic head group of
pyridinium rings and hydrophobic hydrocarbon chains.
The existence of dualistic domains within single mole-
cules critically determines their behaviour in aqueous
solution and bio-activity [1].
In aqueous solution poly-APS above their critical micelar
concentration form irregular spherical aggregates with a
mean radius of 23 nm [1,2]. These consist of multiple pol-
ymer structures that may form active units of poly-APS.
However, most of the observed actions are activities of
single polymers since in biological assays the concentra-
tion used are well below their critical micelar cencentra-
tion. Poly-APS have a number of bio-activities such as
anticholinesterase activity [3], haemolysis [4], and cyto-
toxicity, [5] and many of their actions can be attributed to
poly-APS forming pores in membranes.
Electrophysiological recordings from cultured dorsal root
ganglia (DRG) neurones indicate that poly-APS and
related sponge toxins (halitoxins) collapse membrane
potentials and input resistances. These effects result from
increases in membrane ionic permeability and reduced
ability of cells to maintain electrochemical gradients [6,7].
In the case of poly-APS this pore formation is reversible in
most DRG neurones when concentrations below 5 μg/ml
were used [6]. This is consistent with data from a previous
study by Berlinck and colleagues who showed that halito-
xin from Amphimedon viridis blocked crutacean nerve
action potentials but that partial recovery could be
obtained in some experiments [8].
Due to the reversible nature of the pores formed by poly-
APS at low μg/ml concentrations, it has been possible to
exploit these pores experimentally. For example the trans-
fection of HEK 293 cells with cDNA plasmids for
enhanced green fluorescent protein and human tumour
necrosis factor receptor 2 has been achieved [9]. Addition-
ally, the pore formation and macromolecule delivery is
enhanced at 12°C compared to 21°C. These findings
indicate that pore formation but not endocytosis is a
requirement for efficient macromolecule delivery [10].
It is of great interest that synthetic "poly-APS like" mono-
mers and oligomers have been produced. These com-
pounds express one or more pyridinium rings ranging
from monomers to tetramers, and varying hydrocarbon
chain length (Figure 1 structures 1–4). Some bio-activities
of these synthetic compounds, including: antibacterial,
haemolysis, cholinesterase inhibition and to a lesser
extent protein phosphate 2A inhibition, have already
been characterised. In particular these compounds show
some correlation between the length of the polymer
(degree of polymerization) and functional activity [11].
In this study we have aimed to characterise and compare
the pore-forming properties of poly-APS and four syn-
thetic compounds using primary cultures of rat hippoc-
ampal neurones and evaluate the potential for
intracellular macromolecule delivery into CNS neurones
by any of the compounds.
Results
Acute electrophysiological actions of poly-APS on cultured 
hippocampal neurones
Low-pressure ejection of 0.5 μg/ml poly-APS collapsed
membrane potential from a resting level of -65 ± 3 mV to
-16 ± mV (n = 6; p < 0.01). This effect was accompanied by
suppression of action potential firing evoked by +100 pA
current step commands and reductions in electrotonic
potentials evoked by -100 pA current step commands
(Figure 2A). Under control conditions -100pA current
step commands evoked a mean hyperpolarising electrot-
onic potential of 44.3 ± 7.5 mV, which equated to a mean
input resistance of 443 ± 75 MΩ. After application of poly-
APS for 3 minutes, the mean input resistance was signifi-
cantly reduced to 137.1 ± 24.2 MΩ (n = 6; p < 0.01).
Adjusting for the reduction in membrane potential using
constant current injection, resulted in an input resistance
of 153.6 ± 37.4 MΩ, which was not significantly different
from non-adjusted values (n = 5; p > 0.05, Figure 2B).
Prolonged intracellular recordings revealed a variable
timeline of pore reversibility and cell recovery from poly-
APS (0.5 μg/ml). In one example neurone, approximately
45 minutes after application of poly-APS, a partial recov-
ery of membrane potential and input resistance was
observed (Figure 2C). Prior to poly-APS application the
resting membrane potential was -65 mV and the input
resistance was 308 MΩ. After 5 minutes application of
poly-APS, resting membrane potential and input resist-
ance fell to -18 mV and 115 MΩ respectively, before recov-
ering to -63 mV and 168 MΩ. However, injection of +100
to +300 pA current step commands failed to elicit action
potential firing. Whilst this indicates some reversibility in
the membranes ionic permeability, it suggests that sup-
pression of action potentials firing is not solely due to the
collapse of input resistance but may involve more pro-
longed inactivation of voltage-activated channels and loss
of electrochemical gradients. Figure 2D shows a record of
the onset of the response to brief application of 0.5 μg/mlPage 2 of 17
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brane potential and input resistance collapse. Preliminary
data (n = 4), indicated that if cultures were exposed to
poly-APS (3 minutes, 0.5 μg/ml) and then returned to cul-
ture conditions for 24 hours at least some neurones
recover and have the ability to fire action potentials when
stimulated (Figure 2E).
To further characterise the actions of poly-APS, neurones
were voltage clamped at potentials between -70 and -140
mV in the absence and presence of the natural product
preparation. Figure 3 shows the linear current-voltage
relationships generated under control conditions and in
the presence of poly-APS. Leak subtractions of linear leak
current and capacitance were performed to generate val-
ues for the net poly-APS activated-currents. These showed
a linear correlation with voltage of R2 = 0.94 ± 0.03, a
mean slope conductance of 10.5 ± 3.3 nS. A mean reversal
potential of 10 ± 10.5 mV (n = 9) for the poly-APS-acti-
vated current was obtained from individual experiments
by plotting difference current (after leak subtraction)-volt-
age relationships and identifying the point at which the
linear relationship crosses the x-axis (I = 0).
The poly-APS-evoked currents displayed typical properties
of non-specific cation currents resulting from permeation
of the cell membrane.
Electrophysiological response to application of synthetic 
alkylpyridinium compounds
Each synthetic alkylpyridinium compound was applied to
cultured rat hippocampal neurones at one of two concen-
trations and attempts were made to maintain similar
numbers of pyridinium rings in the different solutions
Structures of compounds used in the studyFigure 1
Structures of compounds used in the study. Poly-APS: repeating subunit for the natural poly-APS, characterised as a mixture of 
polymers with either n = 29 or n = 99. Sample 1: monomeric synthetic compound. Sample 2: Dimeric synthetic compound 
with additional para-methoxybenzyl terminal group and a hydroxyl group on the terminal chain. Sample 3: Tetrameric synthetic 
compound with additional para-methoxybenzyl and tetrahydropyranyl group on the terminal chain. Sample 4: Tetrameric syn-
thetic compound with iodide as substituent on the terminal chain.
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monomer and dimer, sample 1 and 2 respectively, evoked
only small non-uniform transient inward currents. The
peak current amplitude of events induced by sample 1
were < -0.2 nA in size, with duration of < 100 ms. Sample
2 induced transient inward currents at a lower frequency,
but with varying amplitudes ranging from between -0.2
nA and -1 nA, with a greater duration lasting approxi-
mately 300 ms (Figure 4A &4B ). These currents were
recorded within the first few seconds of application of the
test compounds but inward current activity stopped with
persistent application of the test compounds.
The larger synthetic compounds, tetramers 3 and 4, both
produced more sustained inward currents and evoked
action currents of -1.5 to -2 nA (Figure 4C &4D). In con-
trast, the inward currents evoked by samples 1 and 2 rarely
evoked regenerative action currents and did not produce
the high frequency discharge activity. Although poly-APS
produced the largest and most sustained inward currents,
Poly-APS (0.5 μg/ml) reversible elevated ionic permeability and suppressed neuronal excitability in cultured hippocampal neu-r nesFigure 2
Poly-APS (0.5 μg/ml) reversible elevated ionic permeability and suppressed neuronal excitability in cultured hippocampal neu-
rones. a) Electrotonic potentials in response to +/- 100 pA current step. Multiple action potential firing was seen in response to 
+100pA. In the same neurone after 5 minutes application of 0.5 μg/ml poly-APS the electrotonic potential to -100 pA was 
reduced and action potential activation was depressed. B). Application of poly-APS greatly reduced the input resistance. This 
reduction was still observed even when membrane potential changes were corrected (n = 6 for control and poly-APS and n = 
5 for membrane potential (MP) corrected (** = P < 0.01 student paired t-test). C). Voltage records showing the response to 
poly-APS and partial recovery of the input resistance after 45 minutes. D) Voltage record showing membrane potential and 
electrotonic potentials (downward deflections) evoked by -80 pA current pulses and the onset of the response to a brief appli-
cation of poly-APS (0.5 μg/ml). The development of partial recovery can also be seen. E) Voltage records showing action 
potential firing evoked by a +50 pA step command and an electrotonic potential evoked by a -50 pA step command. These 
responses were evoked from a hippocampal neurone that had been exposed to 0.5 μg/ml poly-APS and then placed back in cul-
ture for 24 hours.
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support spontaneous action potential discharges (Figure
4E).
The actions of the synthetic compounds on current-volt-
age relationships (range -70 to -140 mV in 10 mV inter-
vals) were also investigated. Samples 1, 2, 3 and 4, were
tested at concentrations of 5 and 50 μg/ml.
Firstly, we compared the net currents evoked at a holding
voltage of -70 mV, the mean data for all samples are
shown in Figure 5. Poly-APS (0.5 μg/ml) evoked a highly
significant increase in holding current while application
of sample 1 at 5 μg/ml did not significantly alter the hold-
ing current. Under control conditions the mean holding
current was -44 ± 8 pA compared to -42 ± 10 pA (n = 3; p
> 0.05) in the presence of sample 1 (5 μg/ml). At 50 μg/
ml sample 1 also did not alter the mean holding current
at -70 mV (-65 ± 26 pA compared to -67 ± 19 pA (n = 6; p
> 0.05). Sample 2 at 50 μg/ml also did not significantly
alter holding current (n = 4; p > 0.05). Sample 4, the
tetramer compound and structurally most like poly-APS,
also did not change the holding current when tested at 0.5
and 5 μg/ml (n = 4 & 5; p > 0.05). However, sample 3 pro-
duced a significant decrease in holding current when
applied at 5 μg/ml. The holding current decreased from a
mean control value of -70 ± 21 pA to -53 ± 17 pA (n = 4;
p < 0.05). Similarly, at 50 μg/ml sample 3 also decreased
holding current from -99 ± 34pA to -82 ± 39 pA (n = 5; p
< 0.05).
Secondly, we considered the actions of the samples on
current-voltage relationships between -70 and -140 mV.
Comparative responses produced by the different samples
Poly-APS activated inward currents in cultured hippocampal neuronesFigure 3
Poly-APS activated inward currents in cultured hippocampal neurones. Mean current- voltage relationships plotted under con-
trol conditions (broken line) and after activation of inward current by 0.5 μg/ml poly-APS (solid line). Poly-APS application pro-
duced an inward cation current with a linear current/voltage relationship. Inset records show currents evoked by step 
depolarisations to -140 mV from a holding potential of -70 mV under control conditions and in the presence of poly-APS.
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BMC Pharmacology 2007, 7:1 http://www.biomedcentral.com/1471-2210/7/1were statistically analysed using a 2-way ANOVA test and
comparing individual sample responses against controls
at corresponding voltages. Application of poly-APS at 0.5
μg/ml produced a significant effect on the current-voltage
relationship (n = 4; p = 0.0001), which is described in Fig-
ure 3. The Bonferroni post test revealed significant
increases in holding current at all clamped potentials (n =
4; p < 0.01 for -70 and -80 mV, p < 0.001 for -90 to -140
mV).
When applied at 5 μg/ml, sample 1 produced significant
effects on the current-voltage relationship that were evi-
dent at -140 mV. The post-test confirmed a modest but
significant increase in holding current at -140 mV (-191 ±
85 pA under control conditions compared with -274 ± 54
pA in the presence of 5 μg/ml sample 1 (n = 3; p < 0.05).
Similarly, sample 4 tested at 0.5 and 5 μg/ml also pro-
duced a modest but significant increase in the slope of the
current-voltage relationship (n = 4, 5; p < 0.01). However,
sample 2 at 50 μg/ml produced no change in the current-
voltage relationship (n = 4). In contrast, sample 3 tested
at 50 μg/ml showed a modest but significant decrease in
the slope of the current-voltage relationship between -90
and -140 mV (n = 5; p < 0.01). The synthetic compounds
tested showed modest or no significant sustained effects
on the linear current-voltage relationship under voltage
clamp. In summary, despite subtle transient changes in
holding current, none of the synthetic samples produced
currents of the magnitude and duration as those evoked
by poly-APS (n = 3–5; p < 0.01), even when the synthetic
samples were applied at 100 times the concentration of
poly-APS.
Intracellular Ca2+ imaging analysis of the Ca2+ transients 
evoked by poly-APS and the synthetic compounds
Poly-APS were applied in sequential ascending concentra-
tions of 0.005, 0.05, 0.5 and 5 μg/ml. The responses
recorded from hippocampal neurones showed that poly-
APS transiently increased intracellular Ca2+. However,
poly-APS produced a variety of distinct concentration
response relationships. Three distinct poly-APS response
profiles can be seen in Figure 6A. In most neurons
observed (~77% of responding neurons) the amplitudes
of the intracellular Ca2+ transients increased with increas-
ing poly-APS concentrations. However in a second group
with low sensitivity, responses were only seen to the high-
est concentration (5 μg/ml) of poly-APS. A third group of
neurones responded to 0.5 and 5 μg/ml poly-APS but not
to the lowest or intermediate concentrations. When data
from all cells were pooled the poly-APS induced Ca2+ rise
displayed a concentration-dependent response relation-
ship. At concentrations of 0.005, 0.05, 0.5 and 5 μg/ml
poly-APS produced 33 ± 6, 78 ± 5, 159 ± 20 and 154 ± 15
% increase in Ca2+ relative to baseline levels (n = 10; p <
0.001 Kruskal-Wallis). Significant increases in intracellu-
lar Ca2+ levels were observed when comparing responses
to 0.005 μg/ml poly-APS with responses to 0.5 and 5 μg/
ml (n = 10; p < 0.001), and 0.05 μg/ml with 0.5 and 5 μg/
ml (n = 10; p < 0.01; Figure 6B). Analysis of responders
revealed a poly-APS sensitive subpopulation of cultured
hippocampal neurones, with 41 % responding to 5 μg/ml
poly-APS and 30 – 40 % responding to the lower concen-
trations tested. This reflects a consistent threshold sensi-
tivity to low concentrations of poly-APS in a
subpopulation of hippocampal neurones. In most cases
the same cells are responding to different concentrations
of poly-APS. However, some cells that respond to low
concentrations of poly-APS failed to recover preventing
further analysis. The variation in response may be a result
of a heterogenous population of neurons within the hip-
pocampal cultures, whilst the majority of neurones are
likely to be pyramidal cells it is also likely that various
interneurones exist within the culture. Differences in
membrane lipid composition may alter the sensitivity of
neurones to poly-APS. The synthetic compounds were
also applied to hippocampal cultures and changes in
intracellular Ca2+ measured. Similar to the electrophysiol-
ogy results with the synthetic compounds, direct compar-
isons with poly-APS (0.5 μg/ml) were made based on
using concentrations that contained equivalent numbers
of pyridinium rings. Poly-APS (0.5 μg/ml) were also
applied after synthetic compounds to test for the sensitiv-
Table 1: Concentrations of the samples: the values in μg/ml were used in this study to give approximately equivalent numbers of 
pyridinium rings for each compound investigated. The corresponding values in μM are given below
Molecular Weight 0.005 μg/ml 
corresponds to (μM)
0.05 μg/ml 
corresponds to (μM)
0.5 μg/ml 
corresponds to (μM)
5 μg/ml 
corresponds to (μM)
50 μg/ml 
corresponds to (μM)
Poly-APS 12200a) 4* 10-4 4* 10-3 0.04 0.4 4
Monomer
S1
129 3.8* 10-2 0.38 3.8 38 388
Dimer
S2
772 6.5* 10-3 0.065 0.65 6.5 65
Tetramer
S3
1490 3.4* 10-3 0.034 0.34 3.4 34
Tetramer
S4
1268 3.9* 10-3 0.039 0.39 3.9 39
a) Mean molecular weight considering natural poly-APS as a 1:1 mixture of the two polymers with n = 29 and n = 99.Page 6 of 17
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BMC Pharmacology 2007, 7:1 http://www.biomedcentral.com/1471-2210/7/1ity of the neurones. Interestingly, only those neurones
which responded to poly-APS, produced a Ca2+ transient
in response to application of the synthetic compounds. Of
these compounds, only samples 1 and 4 produced signif-
icant increases in intracellular Ca2+ but samples 1, 2 and 3
at 50 μg/ml all gave significantly smaller responses com-
pared to 0.5 μg/ml poly-APS (n>3; p = 0.01 to 0.001).
Only 14 % and 37 % of neurones responded to 5 μg/ml
and 50 μg/ml sample 1. Sample 1 (5 and 50 μg/ml) pro-
duced increases in Ca2+ of 25.3 % and 59 % compared to
baseline levels. The increases in intracellular Ca2+ evoked
by sample 1 (5 & 50 μg/ml) were significantly smaller (11
and 26 %; n = 12 & 14) compared to the mean response
evoked by 0.5 μg/ml poly-APS (n = 96; p < 0.001). All the
neurones that responded to 0.5 μg/ml poly-APS also
responded to 5 μg/ml of sample 4. Sample 4 at 5 μg/ml
produced a 174 % rise in Ca2+ relative to the baseline lev-
els and gave a mean response of 77 % of that induced by
Poly-APS and the related synthetic compounds produced distinctive electrophysiological activityFigure 4
Poly-APS and the related synthetic compounds produced distinctive electrophysiological activity. 5-second traces of current 
activity recorded during the application of A) sample 1, B) sample 2, C) sample 3, D) sample 4, and E) poly-APS by low-pres-
sure ejection. A-D, Synthetic compounds 1–4 produced two distinct forms of activity. Activity was not sustained and stable 
baselines were reached in all cells. Poly-APS produces no spontaneous activity (action currents).
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BMC Pharmacology 2007, 7:1 http://www.biomedcentral.com/1471-2210/7/10.5μg/ml poly-APS (n>3; p < 0.001). Figure 7 summarises
the Ca2+ imaging data and shows maximal responses to
the synthetic samples compared to increases in intracellu-
lar Ca2+ evoked by poly-APS.
DPH Fluorescence imaging
Membrane fluidity was quantified using the lipophilic flu-
orescence probe 1,6-diphenyl-1, 3, 5-hexatriene (DPH).
Initial levels of DPH fluorescence within the membrane
are dependent upon the ratio of lipids, cholesterol and
proteins within the bilayer. Insertions of molecules into
the membrane that are lipophilic increase the fluorescent
signal and indicate a more fluid membrane environment.
However, insertion of non-lipophilic molecules that can
form lipophobic or hydrophilic regions in the membrane
may make the membrane more rigid and decrease the
lipid density [12-14]. This results in a reduced DPH fluo-
rescence indicative of a reduction in membrane fluidity
(Figure 8).
Application of poly-APS in order of ascending concentra-
tion, 0.005 to 5 μg/ml, produced transient reductions in
DPH fluorescence, the magnitudes of which increased
with higher concentrations (Figure 9A). When applied at
0.05, 0.5 and 5 μg/ml, poly-APS decreased fluorescence by
8, 14 and 16 % respectively. The response to 0.05 μg/ml
poly-APS was significantly lower than that produced by 5
μg/ml poly-APS (n = 3; p < 0.001). The responses to poly-
APS appeared to display a straightforward dose-depend-
ent relationship. However, when applied in order of
descending concentrations (5, 0.5 & 0.05 μg/ml), poly-
APS produced cumulative responses (Figure 9B). Both
0.05 and 5 μg/ml poly-APS produced significantly differ-
ent decreases in fluorescence, depending on the sequences
of application. Poly-APS (0.05 μg/ml) decreased fluores-
cence by 9 % and 11 % when applied in ascending and
descending order (n = 3; p < 0.001). In contrast, 5 μg/ml
poly-APS decreased fluorescence by 16 % compared to 11
% when applied in ascending and descending orders (n =
3; p < 0.001; Figure 9C).
Surface plasmon resonance data for poly-APS
Surface Plasmon Resonance (SPR) is a method that uses
changes in light reflection off a metal surface coated with
a target ligand to detect binding and dissociation of a test
analyte. When analyte is associated with the ligand, it
alters the refractive index which can be measured and
used to determine the time course of association and dis-
sociation. In this study we have used SPR to detect inter-
actions between surface-immobilized cholesterol/
Poly-APS evoked larger and more sustained inward currents than did the synthetic compoundsFigure 5
Poly-APS evoked larger and more sustained inward currents than did the synthetic compounds. Bar chart showing changes in 
holding current, at a holding voltage of -70 mV, induced by application of poly-APS and samples 1–4. Only poly-APS (open bar 
A) at 0.5 μg/ml produced a significant inward current (n = 10; P < 0.01 paired t test) compared to resting membrane holding 
current.
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BMC Pharmacology 2007, 7:1 http://www.biomedcentral.com/1471-2210/7/1sphingomyelin lipid vesicles and poly-APS. Given our pre-
vious results and anomalous dose-response relationships
we were particularly interested in determining whether
Poly-APS have a reversible association with lipids.
SPR sensorgrams corrected for bulk effects, displaying the
association-dissociation kinetics of poly-APS interaction
with cholesterol/sphingomyelin (1/1) large unilamellar
vesicles (LUVs) immobilized on L1 chip, are shown in Fig.
10. Increasing kinetics during the association phase (3.3
min) was observed with increasing concentrations sug-
gesting dose-dependent behaviour. However, the binding
of poly-APS did not reach the equilibrium during the 3.3
min application period. Approximately 80% of the signal
persisted during the dissociation step, indicating that a
considerable amount of poly-APS remained irreversibly
inserted or attached to the lipid bilayer. Moreover, succes-
sive injections of poly-APS produced a accumulative bind-
ing effect. For example, the binding signal obtained after
successive treatment of the bilayer with 6 doses of 0.5 μg/
ml poly-APS was enhanced by 40% in comparison with
the first injection over the freshly deposited LUVs (Fig. 10,
inset). These repeatedly observed effects indicate that poly-
APS molecules already present in the membrane can
enhance further binding of poly-APS, and support the
data obtained with calcium imaging and DPH (Fig. 6 & 9).
Discussion
The electrophysiological actions of 0.5 μg/ml poly-APS on
cultured hippocampal neurones were consistent with
pore formation by the sponge toxins and are similar to the
effects previously seen in HEK293 cells and DRG neu-
Poly-APS evoked increases in intracellular Ca2+Figure 6
Poly-APS evoked increases in intracellular Ca2+. A) Example traces from individual neurones exposed to different concentra-
tions of poly-APS during the same Ca2+ imaging experiment. Three different levels of response to poly-APS are seen. The top 
trace shows the most typical responses. B) Bar chart showing relative increases in intracellular Ca2+ in response to increasing 
concentrations of poly-APS sampled from a total of 106 neurones. Data shows trend for dose-response relationship (** = P < 
0.01 ** = P < 0.001). Percentage values are the % of neurones responding to each concentration of poly-APS.
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BMC Pharmacology 2007, 7:1 http://www.biomedcentral.com/1471-2210/7/1rones [6,9]. Additionally, we again observed that within
any of the populations of cultured cells there was a con-
siderable variability in sensitivity to poly-APS. In the cases
of DRG and hippocampal neurones this may be explained
by the heterogeneous nature of the cultures, but some var-
iability is also observed in HEK293 cells. For example,
considering evoked Ca2+ transients in hippocampal neu-
rones, 39 % of neurones responded to 0.5 μg/ml poly-APS
but this value only increased to 41 % when a 10 fold
higher concentration was used. Although all HEK 293
cells responded to 5 μg/ml poly-APS there was great vari-
ability in the threshold sensitivity to this natural com-
pound [9]. Additionally, there is also a large degree of
variability in the currents and Ca2+ transients evoked by
poly-APS. This may relate to the compositions of plasma
membranes providing varying access and/or numbers of
binding sites for the polymeric units to interact with. In
this study we have also revealed a level of variability in
poly-APS responses (both in Ca2+ transients and mem-
brane fluidity measurements) that related to previous
exposure to the natural product. One interpretation of the
findings is that poly-APS polymers do not fully wash out
of membranes but membrane re-modelling takes place to
facilitate repair but disrupt pores. A consequence of this
would be that poly-APS molecules already within the
membranes influence the responses produced by subse-
quent reapplication of poly-APS. This may account for the
complex dose-response relationships seen in this study
that depended on the order of application of different
concentrations of poly-APS.
Recovery of hippocampal neurones from both electro-
physiological responses and in some cases Ca2+ transients
evoked by poly-APS was slow and often incomplete.
Faster (20 minute time frame) and greater levels of recov-
ery (both in numbers {97 %} of cells and amplitudes)
were seen in DRG neurones exposed to 0.5 μg/ml poly-
APS [6]. This may be due to variations in Ca2+ homeosta-
sis in different neurones and predisposition to Ca2+
induced excitotoxicity. However, preliminary data sug-
Synthetic compounds 1–4 produced smaller changes in intracellular Ca2+ compared to poly-APSFigure 7
Synthetic compounds 1–4 produced smaller changes in intracellular Ca2+ compared to poly-APS. A) Bar chart showing mean 
percentage changes in fluorescence compared to baseline values. Samples 1, 2 and 3 produced modest changes in intracellular 
Ca2+ that were significantly smaller than those seen with poly-APS (*P < 0.05, **P < 0.01 & ***P < 0.001). Sample 4 at a concen-
tration of 5 μg/ml gave a similar response to 0.5 μg/ml poly-APS. B) Example traces of mean responses to the synthetic com-
pounds and poly-APS. Each trace is comprised of the mean from 17–34 neurones.
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BMC Pharmacology 2007, 7:1 http://www.biomedcentral.com/1471-2210/7/1gests that 24 hours after exposure to poly-APS, at least
some hippocampal neurones show normal electrophysio-
logical properties and fire action potentials.
Activity of synthetic compounds
Although polymeric alkylpyridinium compounds may be
useful as transfection reagents and for intracellular deliv-
ery of macromolecules, there are clear hurdles that restrict
progress. To date research concerning these natural
metabolites has focused on the isolation from marine
sponges of natural products as cocktails and not on single
pure compounds. Purification of individual polymeric
alkylpyridinium compounds from nature has proved
problematic because of availability and variability of
materials and the complex nature of the mixtures that may
contain tens of molecules with similar molecular weights
and related structures [7]. Additionally, poly-APS for
example might be improved on because they have
recently been found ineffective for the intracellular deliv-
ery of siRNA [10]. Ideally, total synthesis of defined pure
alkylpyridinium polymers would be a way forward.
Although making large polymers by an efficient and con-
trolled synthetic sequence remains a goal, a series of
water-soluble monomers and oligomers, the later -as
short "poly-APS-like" examples, have been made. Analysis
of chemical structure and bioactivity has suggested several
DPH membrane fluorescent measurementsFigure 8
DPH membrane fluorescent measurements. An example record of a poly-APS response showing the measurements made (red 
text). Changes in membrane fluorescence were quantified relative to pre-drug application fluorescence. The change of fluores-
cence intensity was measured for each region of interest as the peak response minus pre-drug fluorescence (Peak-Pre). For 
each individual region of interest the pre-drug baseline fluorescence decay was measured from two time points prior to the 
application of any drug, this provided a base change of DPH intensity (ΔB). Subtraction of ΔB from peak pre-drug response (see 
equation) allowed all responses to be normalised for the decay rate of DPH. Data was finally calculated as a % change of pre-
drug baseline, see inset equation. All measurements were made from individual raw records that were analysed without filter-
ing or smoothing.
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BMC Pharmacology 2007, 7:1 http://www.biomedcentral.com/1471-2210/7/1factors that may influence the extent of membrane inter-
action including: 1) distribution of positive charges, 2)
alkyl chain length and 3) numbers of pyridinium rings.
These properties partially correlate with antibacterial
properties. Although sample 4 showed greater activity
than the other synthetic compounds used in this study it
also shows greater antibacterial activity than poly-APS
[11]. In our study, higher levels of membrane perturba-
tion were seen with sample 4 and to some extent with
sample 3 compared with relative inactivity seen with sam-
ples 1 and 2. Action potential discharges and Ca2+ tran-
sients evoked by sample 4 particularly reflected this.
Structural variation may account for the distinct sets of
transient events evoked by the synthetic compounds and
may provide indications of extents of the compounds sur-
face interactions resulting in the alteration of membrane
charge separation through screening or capacitance
changes. The transient nature of the events induced by
sample 1 and 2 may indicate incomplete membrane inter-
actions such as partial intercalation rather than pore for-
mation. Whilst the more prolonged disruption of holding
current induced particularly by sample 4 may indicate
more stable interactions with membranes. Interaction
with specific membrane proteins such as ionic pumps and
channels may also contribute to the initial small transient
responses observed. In this study, sample 4 produced the
more robust responses compared to sample 3, yet they
share very similar structural features, suggesting that the
presence of additional functional groups on sample 3
inhibits membrane or protein interactions that lead to
activity. In contrast to two of the synthetic compounds (3
and 4), poly-APS did not produce action potential dis-
charges and actually suppressed action potential firing.
This was most likely due to the larger decrease in input
resistance, to a point where regenerative excitability is pre-
vented.
Considerable haemolytic activity was previously seen
with poly-APS inducing lysis of bovine erythrocytes with
an approximately 100 fold higher effect than compound
4 [11]. Our data from cultured hippocampal neurones
was consistent with the findings previously made by Man-
cini et al. who have shown that haemolytic, antibacterial
and anticholinesterase activities of alkylpyridinium com-
pounds mainly increase with higher degrees of oligomer-
isation, numbers of positive charges and pyridinium rings
[11].
Cumulative dose-response relationships showing the actions of poly-APS on membrane fluidityFigure 9
Cumulative dose-response relationships showing the actions of poly-APS on membrane fluidity. A) Mean record of changes in 
fluorescence (membrane fluidity, n = 15 from a single experiment) in response to increasing concentrations of poly-APS (2 
mins application per concentration). The change in density is partially reversible on washing. B) Mean record of changes in flu-
orescence in response to decreasing concentrations of poly-APS (starting with the highest 5 to 0.05 μg/ml, n = 8 from a single 
experiment). C) Bar chart showing the mean responses to poly-APS (n = 103) when the order of application of different con-
centrations of poly-APS was varied. Regardless of the order of application, there is a trend for an increase in % change in mem-
brane fluidity.
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Analysis of the dynamic changes in membrane fluidity in
response to poly-APS provided new insights into possible
mechanisms of pore formation and cell recovery after
pore formation. Poly-APS decreased membrane fluidity
but again showed complex dose-response relationships
that were greatly influenced by the order in which differ-
ent concentrations of natural product were applied. The
cumulative type dose-response relationship may result
from alkylpyridinium compounds remaining within the
lipid membranes, even after the structure has recovered
from pore formation. This was striking, when viewing the
raised levels of membrane disruption produced by 0.005
μg/ml poly-APS, applied after the neurones had been
exposed to higher concentrations of pore-former. We
speculate that poly-APS within the membrane that are not
producing an increase in permeability provide either co-
operative support for further interactions between mem-
branes and poly-APS, or produce sites of membrane vul-
nerability. This increase in membrane vulnerability may
relate to partial membrane repair and increased availabil-
ity of poly-APS binding sites and thus prime the mem-
brane for further poly-APS interactions. The preliminary
SPR data in the present study support these ideas and
showed that a significant proportion of poly-APS remains
in or bound to membranes after washing. Furthermore
the repeated application of poly-APS to membranes
results in accumulation of associated poly-APS and that
accumulation of poly-APS in membranes enhances fur-
ther binding of poly-APS. The nature of this molecular
interaction may have practical implications for the refine-
ment of the transfection protocol utilising poly-APS,
Representative sensorgrams showing poly-APS binding to sphingomyelin/cholesterol (1/1) LUVsFigure 10
Representative sensorgrams showing poly-APS binding to sphingomyelin/cholesterol (1/1) LUVs. 100 μl of poly-APS, dissolved 
in 140 mM NaCl, 20 mM Tris.HCl, 1 mM EDTA, pH 8.0, were injected at 30 μl/min for 3.3 min over the LUVs coupled to a 
Sensor Chip L1 at 25°C. Poly-APS were applied in the following order: 0.005 (A), 0.005 (B), 0.5 (C), and 0.5 (D) μg/ml. Inset: 
Sensorgrams showing the binding signal (A) of 0.5 μg/ml poly-APS applied over the freshly deposited sphingomyelin/cholesterol 
(1/1) LUVs, and (B) the binding signal to the same LUVs after 6 successive injections of poly-APS (0.5 μg/ml). The SPR experi-
ments were run in triplicate.
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BMC Pharmacology 2007, 7:1 http://www.biomedcentral.com/1471-2210/7/1where successive applications of low concentration of
poly-APS may prove less cytotoxic than a single applica-
tion of poly-APS at higher concentrations.
Conclusion
Poly-APS, a naturally occurring mixture of two polymeric
alkylpyridinium compounds produces pore formation in
cultured hippocampal neurones that can be identified
and to some degree quantified using electrophysiology,
Ca2+ and DPH imaging. However, related water-soluble
synthetic compounds ranging from monomers to tetram-
ers produced either no pore formation or modest changes
in membrane permeability. Over the time courses of the
experiments conducted in this study it appears that the
synthetic oligomers do not produce similar effects to poly-
APS. The data indicate that larger synthetic oligomers with
a greater degree of polymerisation than the synthetic mol-
ecules used in this study will be required to mimic poly-
APS and potentially be useful for macromolecule delivery
into hippocampal neurones. Intracellular delivery of mac-
romolecules via poly-APS-induced pores may still prove
problematic because of the levels of recovery and the
requirement for prolonged exposure to pore formers.
Methods
Solutions and test compounds
The extracellular NaCl-based medium used in electro-
physiological experiments contained in mM; 130 NaCl, 3
KCl, 2 CaCl2, 0.6 MgCl2, 1 NaHCO3, 10 N-(2-hydroxye-
thyl) piperazine-N-ethanesulfonic acid (HEPES) and 4
glucose; pH was adjusted to 7.4 with addition of NaOH
and osmolarity adjusted with sucrose to 310–320 Osm/
ml.
The intracellular patch pipette solution contained in mM;
140 KCl, 5 ethylene glycol bis(2-aminoethyl ether)-N, N,
N'N'-tetraacetic acid (EGTA), 0.1 CaCl2, 2 MgCl2, 10
HEPES and 2 adenosine triphosphate (ATP); pH was
adjusted to 7.2 with addition of Tris and osmolarity
adjusted with sucrose to ~310 Osm/ml.
The HEPES buffered saline solution (HBS) contained in
mM; 130 NaCl, 5.4 KCl, 1.8 CaCl2, 1 MgCl2, 10 HEPES
and 25 D-glucose; pH was adjusted to 7.4 with addition
of NaOH.
Protease solution contained 3 mg protease X (Sigma), 3
mg protease XIV (Sigma) dissolved in 3 ml HBS.
Minimum essential medium (MEM) contained 27 ml
MEM (Invitrogen), 3 ml foetal bovine serum (Gibco) and
300 μl L-glutamine.
Neurobasal medium contained 29 ml neurobasal
medium (Invitrogen), 300 μl L-glutamine, 600 μl bovine
serum albumin (BSA) and 50 mM glutamate.
The polymeric 3-akylpyridinium salts (poly-APS) were
isolated and purified from the marine sponge Reniera sarai
as previously reported [1]. A 5 mg/ml stock solution in
distilled water was stored at -20°C. The synthetic "poly-
APS-like" samples 1, 2, 3 &4 were synthesised as previ-
ously reported [11]. The structural peculiarities on the
pyridinium moieties arise from the synthetic strategy
adopted. Experimental concentrations of 0.5 – 50 μg/ml
were prepared either in NaCl- based medium for electro-
physiology or HBS for Ca2+ imaging.
Cell culture
Hooded Liester Neonatal rat pups (1–3 days post natal)
were killed by means of neck dislocation and hippocampi
dissected out and placed in ice-cooled HBS. Hippocampi
were placed in protease solution and mechanically disso-
ciated by finely chopping the tissue. The tissue remained
in the solution being enzymetically dissociated for 40
minutes.
In a sterile hood, tissue was removed from the protease
solution and washed with 1.5 ml HBS and partially disso-
ciated by trituration. The tissue was re-suspended in 1.5
ml HBS and then centrifuged at 1600 rpm for 3 minutes.
The supernatant was removed and replaced with 1.5 ml of
MEM solution previously warmed to 37°C. The tissue was
again triturated and the cell suspension was then spun at
1500 rpm for 2 minutes. The supernatant was removed
and replaced with 0.5 ml of MEM per animal (3 ml) and
triturated a third time.
The final cell suspension was plated on poly-L-lysine
coated dishes and placed at 37°C with 5% CO2 in an incu-
bator for 60 minutes before addition of 2 ml of MEM
medium. The cultures were incubated for 2–3 days before
the MEM medium was removed and replaced with neuro-
basal medium contain 50 μM glutamate. The cultures
were incubated for a further 2 – 3 days before being used
in experiments and all the cultures used in this study were
in culture for 5 to 10 days.
Electrophysiology
The cultures were removed from the neurobasal culture
medium and washed twice with 1 ml extracellular NaCl-
based extracellular solution. All experiments were con-
ducted at room temperature ~21°C. The whole cell
recording technique [15] was used to measure changes in
the electrophysiological properties of neurones in
response to application of test compounds. Membrane
potential, input resistance and holding current were meas-
ured via a low resistance (4 – 10 MΩ) borosilicate patchPage 14 of 17
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back-filled with KCl-based patch pipette filling solution.
An Axoclamp-2A switching voltage clamp amplifier oper-
ated at sampling rate 15–20 kHz was used. Poly-APS and
synthetic compounds were applied to neurones by low-
pressure ejection from a blunted borosilicate patch pipette
positioned approximately 100 μm away from the target
cell being studied. After drug application had stopped,
compounds were allowed to diffuse in the surrounding
bath medium to a negligible concentration as a means of
drug removal. A maximum of two sequential experiments
were conducted using the same culture dish, cells were
washed twice between experiments and target cells
selected from two distant regions of the dishes.
To standardise some measurements of electrotonic poten-
tials (for input resistance) and action potentials, neurones
were held at -70 mV and depolarising and hyperpolarising
current step commands (100 – 300 ms) applied in the
absence and presence of poly-APS or a synthetic com-
pound. Single electrode voltage clamp was used to meas-
ure currents activated by poly-APS and the synthetic
compounds. Currents were activated from a holding
potential of -70 mV and voltage step commands (100 ms)
were applied to generate current-voltage relationships
between -140 and -70 mV. All data were recorded and
stored on digital audio tape (DTR 1200, Biologic). Data
were retrieved and analysed using CED Vclamp software,
where appropriate example traces were recorded using a
chart recorder (Gould pen recorder, 2200S). Statistical
analysis was conducted using Prism software, 2 way
ANOVA, Bonferroni post test and Student's two- tailed,
paired t-tests were used. All data are given as means ±
standard error of the mean with associated p values where
relevant.
Calcium Imaging
Hippocampal cultures were washed with HBS at room
temperature and loaded with the cell-permeable fluores-
cent calcium indicator fura-2-AM (10 μM from a 1 mM
stock solution in dimethylformamide, Molecular Probes,
OR, USA) [16] in 1 ml HBS, for 1 hour in the dark. The
intracellular Ca2+ imaging experiments where conducted
as previously described [6,7,9]. Cultures were perfused
with HBS at a rate of 1 – 2 ml/min, using a gravity per-
fusion system. Images were collected at 1 frame every 3
seconds using Oracal software. All experiments were rep-
licated at least 3 times using dishes from 3 different cul-
tures. The statistical significance of the data were tested
using Kruskal-Wallis test and Dunns multiple comparison
tests, p values are given where relevant.
Membrane Fluidity Measurements
Membrane fluidity was quantified by steady-state fluores-
cence anisotropy using the probe 1,6-diphenyl-1,3,5-hex-
atriene (DPH) [17-19]. The incorporation of this probe
into membranes is accompanied by a strong enhance-
ment of the fluorescent signal. Intercalation of DPH
between lipid acyl chains also enables the measurement
of alterations of membrane order along the lipid acyl
chain axis at deeper portions of the bilayer hydrophobic
region [18].
Hippocampal cell cultures were loaded with 100 μM DPH
(Molecular Probes) in MEM for 1 hour at room tempera-
ture, in the dark. Cultures were then washed and perfused
with HEPES buffered solution (composition in mM: NaCl
130; KCl 5.4; CaCl2 1.8; MgCl2 0.1; HEPES 10; glucose
25), at a rate of 1–2 ml/min, using a gravity perfusion sys-
tem.
A suitable field of cells was identified and excitation and
emission wavelengths of 360 nm and 450 nm respectively
were used to image DPH fluorescence. Approximately 20
images were captured per minute. Poly-APS were applied
at different concentrations for two minute periods. Run-
down in fluorescence intensity occurred rather rapidly
due to the instability of DPH within the membrane this
was accounted for during analysis by subtracting the gra-
dient of run-down for each region of interest (taken as a
change in fluorescence intensity between two points prior
to any drug application, see Figure 8) from any change
that occurred in membrane fluidity during application of
poly-APS. DMSO was used as a standard solvation reagent
to test phase stability of cell membranes [12]. All experi-
ments were replicated at least 3 times using dishes from 3
separate cultures. Statistical significance was conducted
using Kruskal-Wallis test and Dunns multiple comparison
tests, p values are given where relevant.
Preparation of liposomes for surface plasmon resonance
Cholesterol/sphingomyelin large unilamellar vesicles
(LUVs) in a 1/1 molar ratio were formed by removing the
organic solvents from the lipid solution in a rounded flask
with rotary evaporation and final vacuum drying. Lipid
film, at a final concentration range of 1 mg/ml, was
swelled in vesicle buffer (140 mM NaCl, 20 mM TRIS, 1
mM EDTA, pH 8.0), and vortexed vigorously to obtain
multilamellar vesicles. To obtain LUVs of a defined size,
the suspension of multilamellar vesicles was subjected to
8 freeze-thawing cycles, and extruded through 0.1 μm
polycarbonate filters (Avestin, Ottawa, Canada) at 50°C
in the thermostatically controlled water bath.
Lipid concentration was determined colorimetrically with
Waco Free Cholesterol C and Wako test Phospholipids B
(990–54009) kits (Waco Chemicals GmbH, Germany).Page 15 of 17
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Binding of poly-APS to immobilized cholesterol/sphingo-
myelin (1/1) LUVs was determined using a Biacore × SPR
apparatus and an L1 Sensor Chip (Biacore AB, Uppsala,
Sweden), that retains intact liposomes on its lipophilic
surface [20]. Using this technique, we were able to directly
monitor the interaction between poly-APS and lipid bilay-
ers. All ligands and washing chemicals were prepared in
the degassed vesicle buffer, which was previously filtered
through a 0.22 μm filter, and which was also used as a
running buffer. 10 μL of LUVs (0.5 mM) were deposited
on the chip surface at a flow rate of 1 μL/min to reach a
response of 11000–11500 resonance units (RU). Loosely
adsorbed lipid materials were washed out successively
with 100 μL of 100 mM NaOH (30 μL/min) and with run-
ning buffer. 100 μL of poly-APS (0.005 or 0.5 μg/ml in the
running buffer) were subsequently injected over immobi-
lized LUVs at a flow rate of 30 μL/min, followed by the
continuous flow of the running buffer to obtain dissocia-
tion kinetics. Sensorgrams were recorded at 25°C. At the
end of experiments, the chip surface was purged with 100
μL of isopropanol: 100 mM NaOH (2:3, v/v), and fresh
LUVs were applied following the above procedure.
Controls were run by applying poly-APS alone to the chip
surface, and bulk controls were run on immobilized vesi-
cles with vesicle buffer alone. Sensorgrams were processed
and evaluated using the BIAevaluation Version 3.2 soft-
ware (Biacore AB, Uppsala, Sweden). No fitting of the
experimental curves was performed, due to the complex
association/dissociation kinetics.
Abbreviations
DPH 1,6-diphenyl-1,3,5-hexatriene
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LUVs large unilamellar vesicles
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siRNA small interfering RNA
SPR Surface plasmon resonance
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